Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

9am.health Launches Virtual Diabetes Clinic to Provide Care to Millions Living with Diabetes

9am.health also announces $3.7 million in seed funding to bring physician-prescribed, personalized treatment plans to people nationwide

9am.health

News provided by

9am.health Inc.

Sep 20, 2021, 07:30 ET

Share this article

Share toX

Share this article

Share toX

SAN DIEGO, Sept. 20, 2021 /PRNewswire/ -- 9am.health, a new virtual diabetes clinic delivering personalized, affordable and kind care directly to consumers, today announced the launch of its unique virtual care platform, which provides comprehensive, affordable and compassionate care to people living with prediabetes or type 2 diabetes. The company also announced $3.7 million in seed funding, which included participation from Founders Fund, Define Ventures, Speedinvest and iSeed Ventures.

9am.health gives people living with prediabetes and type 2 diabetes their own digital front door to healthcare, providing seamless access to many of the most important medications and at-home tests that patients need for one low monthly cost -- delivered quickly and discreetly to their front door. Subscribers to 9am.health also get personalized treatment plans that come with 24/7 access to patient care advocates that can answer any patient need safely from their homes.

Consumers subscribe to 9am.health on the 9am.health website on any device, fill out a brief medical questionnaire, then get connected with a licensed medical provider to be prescribed the most appropriate medications. 9am.health currently provides tailored medication management for those with prediabetes and type 2 diabetes who also may have common comorbidities, like hypertension (high blood pressure) and hyperlipidemia (high cholesterol). Subscribers also can optimize their care plan for greater personalization by adding at-home A1C and cholesterol testing for a small cost that includes shipping and lab analysis. While 9am.health currently does not support injectable medications that some people living with type 2 diabetes need (e.g. insulin), the company plans to continue adding medications to its platform over time.

"Over the last few decades, there have been great technologies and medications developed that have helped many of us living with diabetes. But, if you look at the average standard of care for people living with type 2 diabetes, the picture is very bleak. Costs have increased massively, but outcomes haven't gotten better. It's time we ask ourselves why," said Frank Westermann, co-founder and co-CEO of 9am.health. "At 9am.health, we are creating a new, better and completely virtual experience for diabetes care. We make it affordable for everyone, super easy to use and have an incredible care team who is there for people whenever they need support."

Diabetes is one of the costliest, most debilitating chronic diseases in the United States, totaling more than $327 billion annually. Type 2 diabetes accounts for approximately 90 to 95 percent of the 34 million+ diabetes cases in the U.S., and an additional 88 million American adults have prediabetes.

Even with insurance, the costs for people living with diabetes can be staggering. The average person spends approximately $16,750 per year on medical expenses and experience costs approximately 2.3 times higher than if they didn't have the disease. Additionally, nearly 98 percent of American adults with type 2 diabetes have at least one comorbidity, and nearly 90 percent have two comorbidities -- two of the most common being high blood pressure and high cholesterol.

"With in-home healthcare more important than ever, 9am.health is addressing a massive need both traditional and virtual care providers have ignored," said Scott Nolan, Partner at Founders Fund. "The 9am.health team is using its expertise and pharma relationships to improve the lives of consumers living with diabetes through comprehensive, dedicated, virtual care."

"The diabetes epidemic is just too big for a concierge medicine approach, which is why 9am.health is well-positioned to disrupt a market that is in desperate need of an overhaul. The team is already proven, and their passion is clear," said Lynne Chou O'Keefe, founder and managing partner at Define Ventures. "Americans need more affordable, integrated solutions that combine medication management and virtual care to create a lifestyle change, so we're proud to be an early investor in 9am.health."

Outside of cost barriers, patients seeking diabetes care often face difficulties finding a provider that works for them. It can take weeks to see a doctor, and appointment availability is often limited to times when people have to work. Moreover, a Johns Hopkins study found that many PCPs have significant gaps in overall knowledge of risk factors, diagnostic criteria and recommended management and prevention practices for prediabetes.

There is also the stigma associated with the condition, especially among young Americans. Nearly half of millennials and about a third of Gen Xers report hiding their condition out of worry about what others think.

However, 9am.health deeply understands the life experiences of diabetes patients and was founded by a team of veteran healthcare leaders, including executives behind one of the most successful digital diabetes programs globally, mySugr (acquired by Roche in 2017). The program surrounds patients with a care team of knowledgeable and empathetic healthcare experts, including licensed providers, pharmacists and a team of diabetes care and education specialists that help people best manage their conditions. Subscribers have unlimited chat-based communication with their care team, with phone- and video-based consultations with patient advocates available, when needed.

9am.health is currently available in 33 states, and subscriptions start at $25 per month, which includes the first medication prescription, home delivery and unlimited support from the care team via chat. Each additional medication is an additional $5, and at-home testing for A1C or lipid screening is available for $15 per month, which includes delivery and lab analysis.

With today's investment, the company plans to scale quickly. In the future, 9am.health will look to expand its services to at-home diabetes and prediabetes screening, providing a comprehensive program that compassionately onboards patients into a life managing their conditions. 9am.health also is in discussions with multiple pharmaceutical manufacturers to support additional medications not already included in its program.

About 9am.health

9am.health is a virtual diabetes clinic providing people living with prediabetes and type 2 diabetes with affordable medications and personalized, compassionate care. Founded in 2021 by the management team behind mySugr, 9am.health is available directly to consumers through a low-cost monthly subscription and connects people with a care team of licensed providers, pharmacists and diabetes education and care specialists. Headquartered in San Diego, 9am.health is backed by Founders Fund, Define Ventures, Speedinvest and iSeed Ventures. For more information, please visit www.9am.health.

SOURCE 9am.health Inc.

Related Links

https://www.9am.health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.